PBEF Neutralizing Humanized Monoclonal Antibodies As Novel Therapeutic Approaches

Select Past Funding
Investigator(s): 
Joe G.N. Garcia, MD
Aqualung Therapeutics, Corp
Type: 
R41/STTR (NIH/NHLBI), 2011-2014
Total Dollars: 
$630,000